Pet dander and difficult-to-control asthma: Therapeutic options

Allergy and Asthma Proceedings

Volumn 31, Issue 5, 2010, Pages 385-391

  Ling, Morris ^a   Long, Aidan A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLERGEN; OMALIZUMAB;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; CAT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DISEASE ASSOCIATION; DOG; DRUG EFFICACY; DRUG SAFETY; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOTHERAPY; PEAK EXPIRATORY FLOW; PET ANIMAL; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; SENSITIZATION;

ALLERGENS; ANIMALS; ANTIBODIES, MONOCLONAL; ASTHMA; CATS; DESENSITIZATION, IMMUNOLOGIC; DOGS; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; PETS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77958101726     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2010.31.3390     Document Type: Conference Paper

References (58)

1. Platts-Mills TA, Vervloet D, Thomas WR, et al. Indoor allergens and asthma: Report of the Third International Workshop. J Allergy Clin Immunol 100:S2-S24, 1997. (Pubitemid 128717763)
2. Plaschke P, Janson C, Balder B, et al. Adult asthmatics sensitized to cats and dogs: Symptoms, severity, and bronchial hyperresponsiveness in patients with furred animals at home and patients without these animals. Allergy 54:843-850, 1999.
3. Pope AM, Patterson R, Burge H, and Institute of Medicine (U.S.). Committee on the Health Effects of Indoor Allergens. Indoor Allergens: Assessing and Controlling Adverse Health Effects. Introduction, Washington, D.C.: National Academy Press, 34-43, 1993.
4. Murray AB, Ferguson AC, and Morrison BJ. The frequency and severity of cat allergy vs. dog allergy in atopic children. J Allergy Clin Immunol 72:145-149, 1983.
5. Bush RK. Indoor allergens, environmental avoidance, and allergic respiratory disease. Allergy Asthma Proc 29:575-579, 2008.
6. Platts-Mills TA, Thomas WR, Aalberse RC, et al. Dust mite allergens and asthma: Report of a second international workshop. J Allergy Clin Immunol 89:1046-1060, 1992.
7. Custovic A, Green R, Fletcher A, et al. Aerodynamic properties of the major dog allergen Can f 1: Distribution in homes, concentration, and particle size of allergen in the air. Am J Respir Crit Care Med 155:94-98, 1997.
8. Luczynska CM, Li Y, Chapman MD, and Platts-Mills TA. Airborne concentrations and particle size distribution of allergen derived from domestic cats (Felis domesticus). Measurements using cascade impactor, liquid impinger, and a two-site monoclonal antibody assay for Fel d I. Am Rev Respir Dis 141:361-367, 1990.
9. American Veterinary Medical Association. U.S. pet ownership & Demographics Sourcebook. Schaumburg, IL: Center for Information Management. Available online at www.avma.org/reference/marketstats/sourcebook.asp; last accessed May 25, 2010.
10. Arbes SJ Jr, Cohn RD, Yin M, et al. Dog allergen (Can f 1) and cat allergen (Fel d 1) in US homes: Results from the National Survey of Lead and Allergens in Housing. J Allergy Clin Immunol 114:111-117, 2004.
11. Bollinger ME, Eggleston PA, Flanagan E, and Wood RA. Cat antigen in homes with and without cats may induce allergic symptoms. J Allergy Clin Immunol 97:907-914, 1996. (Pubitemid 26116983)
12. Wood RA, Mudd KE, and Eggleston PA. The distribution of cat and dust mite allergens on wall surfaces. J Allergy Clin Immunol 89:126-130, 1992.
13. Custovic A, Green R, Taggart SC, et al. Domestic allergens in public places. II: Dog (Can f 1) and cockroach (Bla g 2) allergens in dust and mite, cat, dog and cockroach allergens in the air in public buildings. Clin Exp Allergy 26:1246-1252, 1996.
14. Custovic A, Fletcher A, Pickering CA, et al. Domestic allergens in public places III: House dust mite, cat, dog and cockroach allergens in British hospitals. Clin Exp Allergy 28:53-59, 1998.
15. Patchett K, Lewis S, Crane J, and Fitzharris P. Cat allergen (Fel d 1) levels on school children's clothing and in primary school classrooms in Wellington, New Zealand. J Allergy Clin Immunol 100:755-759, 1997.
16. Partti-Pellinen K, Marttila O, Makinen-Kiljunen S, and Haahtela T. Occurrence of dog, cat, and mite allergens in public transport vehicles. Allergy 55:65-68, 2000.
17. Berge M, Munir AK, and Dreborg S. Concentrations of cat (Fel d 1), dog (Can f 1) and mite (Der f 1 and Der p 1) allergens in the clothing and school environment of Swedish schoolchildren with and without pets at home. Pediatr Allergy Immunol 9:25-30, 1998.
18. Chan-Yeung M, McClean PA, Sandell PR, et al. Sensitization to cat without direct exposure to cats. Clin Exp Allergy 29:762-765, 1999.
19. Almqvist C, Larsson PH, Egmar AC, et al. School as a risk environment for children allergic to cats and a site for transfer of cat allergen to homes. J Allergy Clin Immunol 103:1012-1017, 1999.
20. Almqvist C, Wickman M, Perfetti L, et al. Worsening of asthma in children allergic to cats, after indirect exposure to cat at school. Am J Respir Crit Care Med 163:694-698, 2001.
21. Wood RA, Chapman MD, Adkinson NF Jr, and Eggleston PA. The effect of cat removal on allergen content in household-dust samples. J Allergy Clin Immunol 83:730-734, 1989.
22. Busse PJ, Wang JJ, and Halm EA. Allergen sensitization evaluation and allergen avoidance education in an inner-city adult cohort with persistent asthma. J Allergy Clin Immunol 116:146-152, 2005.
23. Nageotte C, Park M, Havstad S, et al. Duration of airborne Fel d 1 reduction after cat washing. J Allergy Clin Immunol 118:521-522, 2006.
24. de Blay F, Chapman MD, Platts-Mills TA. Airborne cat allergen (Fel d I). Environmental control with the cat in situ. Am Rev Respir Dis 143:1334-9, 1991.
25. Avner DB, Perzanowski MS, Platts-Mills TA, and Woodfolk JA. Evaluation of different techniques for washing cats: Quantitation of allergen removed from the cat and the effect on airborne Fel d 1. J Allergy Clin Immunol 100:307-312, 1997.
26. Klucka CV, Ownby DR, Green J, and Zoratti E. Cat shedding of Fel d I is not reduced by washings, Allerpet-C spray, or acepromazine. J Allergy Clin Immunol 95:1164-1171, 1995.
27. Hodson T, Custovic A, Simpson A, et al. Washing the dog reduces dog allergen levels, but the dog needs to be washed twice a week. J Allergy Clin Immunol 103:581-585, 1999.
28. Sublett JL, Seltzer J, Burkhead R, et al. Air filters and air cleaners: Rostrum by the American Academy of Allergy, Asthma & Immunology Indoor Allergen Committee. J Allergy Clin Immunol 125:32-38, 2010.
29. Wood RA, Johnson EF, Van Natta ML, et al. A placebo-controlled trial of a HEPA air cleaner in the treatment of cat allergy. Am J Respir Crit Care Med 158:115-120, 1998.
30. van der Heide S, van Aalderen WM, Kauffman HF, Dubois AE, de Monchy JG. Clinical effects of air cleaners in homes of asthmatic children sensitized to pet allergens. J Allergy Clin Immunol 104:447-51, 1999.
31. van der Brempt X, Charpin D, Haddi E, et al. Cat removal and Fel d I levels in mattresses. J Allergy Clin Immunol 87:595-596, 1991.
32. Morris A. Aero-allergen avoidance measures - Effective or futile? Curr Allergy Clin Immunol 21:1-2, 2008.
33. Ohman JL Jr, Findlay SR, and Leitermann KM. Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses. J Allergy Clin Immunol 74:230-239, 1984.
34. Bertelsen A, Andersen JB, Christensen J, et al. Immunotherapy with dog and cat extracts in children. Allergy 44:330-335, 1989.
35. Hedlin G, Graff-Lonnevig V, Heilborn H, et al. Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment. J Allergy Clin Immunol 87:955-964, 1991.
36. Haugaard L, Dahl R, and Jacobsen L. A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: Clinical efficacy and side effects. J Allergy Clin Immunol 91:709-722, 1993.
37. Alvarez-Cuesta E, Cuesta-Herranz J, Puyana-Ruiz J, et al. Monoclonal antibody-standardized cat extract immunotherapy: Risk-benefit effects from a double-blind placebo study. J Allergy Clin Immunol 93:556-566, 1994.
38. Varney VA, Edwards J, Tabbah K, et al. Clinical efficacy of specific immunotherapy to cat dander: A double-blind placebo-controlled trial. Clin Exp Allergy 27:860-867, 1997. (Pubitemid 27359850)
39. Nelson HS, Oppenheimer J, Vatsia GA, and Buchmeier A. A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract. J Allergy Clin Immunol 92:229-236, 1993.
40. Alvarez-Cuesta E, Berges-Gimeno P, Gonzalez-Mancebo E, et al. Sublingual immunotherapy with a standardized cat dander extract: Evaluation of efficacy in a double blind placebo controlled study. Allergy 62:810-817, 2007.
41. Cox LS, Larenas Linnemann D, Nolte H, et al. Sublingual immunotherapy: A comprehensive review. J Allergy Clin Immunol 117:1021-1035, 2006.
42. Norman PS, Ohman JL Jr, Long AA, et al. Treatment of cat allergy with T-cell reactive peptides. Am J Respir Crit Care Med 154:1623-1628, 1996.
43. Pene J, Desroches A, Paradis L, et al. Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats. J Allergy Clin Immunol 102:571-578, 1998.
44. Simons FE, Imada M, Li Y, et al. Fel d 1 peptides: Effect on skin tests and cytokine synthesis in cat-allergic human subjects. Int Immunol 8:1937-1945, 1996.
45. Maguire P, Nicodemus C, Robinson D, et al. The safety and efficacy of ALLERVAX CAT in cat allergic patients. Clin Immunol 93:222-231, 1999.
46. Oldfield WL, Kay AB, and Larche M. Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects. J Immunol 167:1734-1739, 2001.
47. Oldfield WL, Larche M, and Kay AB. Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: A randomised controlled trial. Lancet 360:47-53, 2002.
48. Alexander C, Tarzi M, Larche M, and Kay AB. The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects. Allergy 60:1269-1274, 2005.
49. Alexander C, Ying S, A BK, and Larche M. Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+; CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects. Clin Exp Allergy 35:52-58, 2005.
50. Smith TR, Alexander C, Kay AB, et al. Cat allergen peptide immunotherapy reduces CD4(+) T cell responses to cat allergen but does not alter suppression by CD4(+) CD25(+) T cells: A double-blind placebo-controlled study. Allergy 59:1097-1101, 2004.
51. National Asthma Education and Prevention Programs. Expert panel report 3: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung, and Blood Institute. 2007.
52. Berkowitz RB, Braker S, Lutz C, et al. Efficacy of fexofenadine in the prophylactic control of cat allergen-induced allergic rhinitis. Ann Allergy Asthma Immunol 96:327-333, 2006.
53. Findlay SR, Barden JM, Easley CB, and Glass M. Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma. J Allergy Clin Immunol 89:1040-1045, 1992.
54. Wood RA, and Eggleston PA. The effects of intranasal steroids on nasal and pulmonary responses to cat exposure. Am J Respir Crit Care Med 151:315-320, 1995.
55. Massanari M, Kianifard F, Zeldin RK, and Geba GP. Efficacy of omalizumab in cat-allergic patients with moderate-to-severe persistent asthma. Allergy Asthma Proc 30:534-539, 2009.
56. Corren J, Wood RA, Patel D, et al. A randomized, double-blind, placebo-controlled, parallel-group study of the efficacy of omalizumab in prevention of bronchoconstriction following environmental aeroallergen exposure. Am Acad Allergy Asthma Immunol J Allergy Clin Immunol 125:AB 72, 2010.
57. Zhu D, Kepley CL, Zhang K, et al. A chimeric human-cat fusion protein blocks cat-induced allergy. Nat Med 11:446-449, 2005.
58. Terada T, Zhang K, Belperio J, et al. A chimeric human-cat Fcgamma-Fel d 1 fusion protein inhibits systemic, pulmonary, and cutaneous allergic reactivity to intratracheal challenge in mice sensitized to Fel d1, the major cat allergen. Clin Immunol 120:45-56, 2006.